Sculptor Capital’s Globus Medical GMED Stock Holding History

Sculptor Capital’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$237M	Sell	3,000,000 -58,000	-2%	-$4.93M	1.93%	8
2026 Q1	$263M	Buy	3,058,000 +58,000	+2%	+$5.21M	2.74%	7
2025 Q4	$262M	Sell	3,000,000 -500,000	-14%	-$38M	2.7%	6
2025 Q3	$200M	Buy	3,500,000 +739,312	+27%	+$42.6M	2.37%	6
2025 Q2	$163M	Buy	2,760,688 +667,850	+32%	+$43.1M	2.3%	6
2025 Q1	$153M	Buy	2,092,838 +15,000	+0.7%	+$1.24M	2.93%	3
2024 Q4	$172M	Sell	2,077,838 -132,900	-6%	-$10.5M	2.29%	9
2024 Q3	$158M	Hold	2,210,738	–	–	2.65%	6
2024 Q2	$151M	Hold	2,210,738	–	–	2.85%	6
2024 Q1	$119M	Buy	2,210,738 +1,484,000	+204%	+$79.8M	2.31%	8
2023 Q4	$38.7M	Buy	+726,738	New	+$35.4M	0.82%	36

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Sculptor Capital's GMED Position: Q2 2026 in Review

Sculptor Capital reduced its Globus Medical (GMED) stake by 1.9% in Q2 2026, selling an estimated $4.93M and leaving 3,000,000 shares worth $237M. The position accounts for 1.93% of the portfolio, ranked #8.

Sculptor Capital first reported a position in GMED in Q4 2023 and has held it in 11 quarters since. The position peaked at $263M in Q1 2026. 597 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Sculptor Capital held 3,000,000 shares of Globus Medical worth $237M as of Q2 2026.
Sculptor Capital sold 58,000 Globus Medical shares in Q2 2026, an estimated $4.93M.
Globus Medical made up 1.93% of Sculptor Capital's portfolio in Q2 2026, its #8 holding.
Sculptor Capital first reported a position in Globus Medical in Q4 2023 and has held it in 11 quarters since.
Sculptor Capital's Globus Medical position peaked at $263M in Q1 2026.
597 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Sculptor Capital's 13F filing for Q2 2026, filed 14 Aug 2026.